Iqvia launches new eCOA platform to quantify the patient experience
Iqvia today launched a new “patient centered endpoints” solution, which captures the patient experience during clinical trials and real world studies, says SVP.
Archives for June 25, 2019
WuXi Clinical looks to bridge ‘the gap between China and the rest of the world’
WuXi Clinical is expanding therapeutically - investing ‘heavily’ in oncology, CNS, GI - and plans to continue growing geographically as well, with a mission to bridge the gap between China and the rest of the world.
Parexel taps into CluePoints risk monitoring to improve clinical data accuracy
Parexel and CluePoints to use CSM solutions for preclinical and clinical risk-based monitoring, after regulatory guidelines impact mutual acceptance of data across the US, EU and Japan.
BMS has to divest blockbuster to complete Celgene acquisition
The share price of BMS sank by over 7% after it stated that it would need to divest Celgene’s Otezla, a blockbuster treatment for psoriasis and psoriatic arthritis.
AbbVie looks to post-Humira growth with $63bn Allergan buyout
AbbVie decides to move forward with a buyout of Allergan, after the latter company’s share price experienced a decline over recent years.
Migraine treatment ‘on track’ for NDA after site qualification
Zosano completes site qualification batches for its subcutaneous investigational migraine treatment and readies itself for NDA submission by the end of year.